US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 738.000
  • -6.500-0.87%
Close Nov 22 16:00 ET
  • 738.000
  • 0.0000.00%
Post 20:01 ET
81.10BMarket Cap18.25P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Regeneron Pharmaceuticals Q3 2024 Earnings Date

Currency：USDOct 31, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
3.67B
3.72B
+53.88M
Beat Est.
+9.04%
+10.65%
+1.47%
EPS
9.58
11.54
+1.96
Beat Est.
+7.81%
+29.81%
+20.41%
Analyst Rating
Buy

Nov 14, 2024

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.630B--
--2024/Q4-- / 3.753B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

  • Regeneron Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Oct 31 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Third Quarter 2024 Financial and Operating Results

    Oct 31 07:15 ET

  • Regeneron Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 07:21 ET

  • Regeneron Pharmaceuticals | 8-K: Regeneron Reports Second Quarter 2024 Financial and Operating Results

    Aug 1 07:11 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Buy

    • Buy

      75.00%

    • Hold

      20.83%

    • Sell

      4.17%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Investment Theme Infectious Disease
    Infectious Disease
    Intraday+0.43%